Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study - Concepedia

Concepedia

Publication | Open Access

Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study

DOI Full Paper Access

54

Citations

8

References

2020

Year

Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, H. Léna, Jesus Corral Jaime, Jhanelle E. Gray, John D. Powderly, C. Chouaïd,

References

	Year	Citations

Page 1